CliffBio
small molecule

CHLORHEXIDINE GLUCONATE

CHLORHEXIDINE GLUCONATE

Loss of exclusivity—loss of exclusivity
CompanyBecton, Dickinson and →See this company's full patent-cliff portfolio

Drug detail

Brand nameCHLORHEXIDINE GLUCONATE
Active ingredientCHLORHEXIDINE GLUCONATE
Strength4%
Dosage formSPONGE
RouteTOPICAL
ModalitySmall molecule
FDA approvalOctober 1989
Marketing statusOTC

More from Becton, Dickinson and

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CHLORHEXIDINE GLUCONATE patent cliff — loss of exclusivity — | CliffBio